Skip to main content
Top
Published in: Drugs & Aging 4/2001

01-04-2001 | Review Article

Clinical Implications of Physiological Changes in the Aging Heart

Authors: K. Gregory Pugh, Dr Jeanne Y. Wei

Published in: Drugs & Aging | Issue 4/2001

Login to get access

Abstract

Elderly individuals experience a disproportionate burden from cardiovascular disease. Global changes in aging will have a significant impact on the future of medical practice. However, most physicians have little formal training in geriatric medicine and sometimes fail to distinguish disease states from normal aging. Increasingly, it is recognised that a sedentary lifestyle may be responsible for a large fraction of the so-called ‘age-related’ changes in the cardiovascular system. Nonetheless, well characterised changes do occur in most individuals with aging. Loss of myocytes with subsequent hypertrophy of the remaining cells is usually observed. Calcification involving the conduction and valvular apparatus is seen in most elderly individuals and may predispose to the common arrhythmias of old age. Age-related loss of arterial compliance contributes to isolated systolic hypertension and left ventricular hypertrophy.
Despite these changes, for the majority of healthy older adults, cardiac output is well maintained in the basal state through use of the Frank-Starling principle, in the setting of reduced early diastolic filling. Myocardial relaxation is slowed in part due to age-related changes in the sarcoplasmic reticulum Ca2+ ATPase pump. Elevated blood levels of catecholamines contribute to desensitisation to noradrenergic stimulation and this is associated with an age-related decline in maximum achievable heart rate. Changes in the baroreceptor reflex function and decreased sodium conservation may predispose some individuals to orthostatic and postprandial hypotension.
The aetiology of cardiovascular aging is under intense study. The most likely mechanisms involve the result of cumulative damage mediated through a variety of insults. Oxidative stress, non-enzymatic glycation, inflammation and changes in cardiovascular gene expression all seem to influence cardiovascular aging.
The benefits of exercise continue to be discovered. Endurance-type training has been shown to have a dramatic impact on parameters of cardiovascular aging. Favourable effects are seen in maximum oxygen consumption, diastolic filling, relaxation and arterial stiffness. Some changes such as the maximum heart rate response do not appear to change with conditioning. Pharmacotherapy may afford the opportunity to influence the aging process. Drugs that can reduce age-associated arterial stiffness, cardiac fibrosis and ventricular hypertrophy should prove useful. Antioxidants continue to be a topic of great interest and require more study.
Despite some well described changes with aging, most elderly individuals maintain the opportunity for improved cardiovascular function through conditioning. Early recognition and treatment of diseases that are distinguishable from normal aging, including hypertension and atherosclerosis, together with preventive efforts, should reduce the predicted trends in cardiovascular morbidity and mortality among the aged.
Literature
1.
go back to reference Foot DK, Lewis RP, Pearson TA, et al. Demographics and cardiology, 1950–2050. J Am Coll Cardiol 2000; 35: 1067–81PubMedCrossRef Foot DK, Lewis RP, Pearson TA, et al. Demographics and cardiology, 1950–2050. J Am Coll Cardiol 2000; 35: 1067–81PubMedCrossRef
2.
go back to reference Premen AJ. Research Recommendations for cardiovascular aging research. NIA Cardiovacular Aging Advisory Panel. J Am Geriatr Soc 1996; 44: 1114–7PubMed Premen AJ. Research Recommendations for cardiovascular aging research. NIA Cardiovacular Aging Advisory Panel. J Am Geriatr Soc 1996; 44: 1114–7PubMed
3.
go back to reference Batchelor WB, Jollis JG, Friesinger GC. The challenges of health care delivery to the elderly patient with cardiovascular disease: demographic, epidemiologic, fiscal, and health policy implications. Cardiol Clin 1999; 17: 1–15PubMedCrossRef Batchelor WB, Jollis JG, Friesinger GC. The challenges of health care delivery to the elderly patient with cardiovascular disease: demographic, epidemiologic, fiscal, and health policy implications. Cardiol Clin 1999; 17: 1–15PubMedCrossRef
5.
go back to reference Cassel CK. In defense of a department of geriatrics. Ann Intern Med 2000; 4: 297–301 Cassel CK. In defense of a department of geriatrics. Ann Intern Med 2000; 4: 297–301
6.
go back to reference Lakatta EG. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999; 47: 613–25PubMed Lakatta EG. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999; 47: 613–25PubMed
7.
go back to reference Katzel LI, Fleg JL, Busby-Whitehead JM, et al. Exerciseinduced silent myocardial ischemia in master athletes. Am J Cardiol 1998; 81: 261–5PubMedCrossRef Katzel LI, Fleg JL, Busby-Whitehead JM, et al. Exerciseinduced silent myocardial ischemia in master athletes. Am J Cardiol 1998; 81: 261–5PubMedCrossRef
8.
go back to reference Olivetti G, Melissari M, Capasso JM, et al. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68; 1560–8PubMedCrossRef Olivetti G, Melissari M, Capasso JM, et al. Cardiomyopathy of the aging human heart: myocyte loss and reactive cellular hypertrophy. Circ Res 1991; 68; 1560–8PubMedCrossRef
10.
go back to reference Olivetti G, Cigola E, Maestri R, et al. Recent advances in cardiac hypertrophy. Cardiovasc Res 2000; 45: 68–75PubMedCrossRef Olivetti G, Cigola E, Maestri R, et al. Recent advances in cardiac hypertrophy. Cardiovasc Res 2000; 45: 68–75PubMedCrossRef
11.
go back to reference Hayward CS, Kelly RP, Collins P. The role of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000; 46: 28–49PubMedCrossRef Hayward CS, Kelly RP, Collins P. The role of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000; 46: 28–49PubMedCrossRef
12.
go back to reference Goor D, Lillehei CW, Edwards JE. The sigmoid septum: variation in the contour of the left ventricular outlet. Am J Roentgenol Radium Ther Nucl Med 1969; 107: 366–76PubMed Goor D, Lillehei CW, Edwards JE. The sigmoid septum: variation in the contour of the left ventricular outlet. Am J Roentgenol Radium Ther Nucl Med 1969; 107: 366–76PubMed
13.
go back to reference Shapiro LM, Howat AP, Crean PA, et al. An echocardiographic study of localized subaortic hypertrophy. Eur Heart J 1986; 7: 127–32PubMed Shapiro LM, Howat AP, Crean PA, et al. An echocardiographic study of localized subaortic hypertrophy. Eur Heart J 1986; 7: 127–32PubMed
14.
go back to reference Swinne CJ, Shapiro EP, Jamart J, et al. Age-associated changes in left ventricular outflow tract geometry in normal subjects. Am J Cardiol 1996; 76: 1070–3CrossRef Swinne CJ, Shapiro EP, Jamart J, et al. Age-associated changes in left ventricular outflow tract geometry in normal subjects. Am J Cardiol 1996; 76: 1070–3CrossRef
15.
go back to reference Henein MY, O’Sullivan C, Sutton GC, et al. Stress-induced left ventricular outflow tract obstruction: a potential cause of dyspnea in the elderly. J Am Coll Cardiol 1997; 30: 1301–7PubMedCrossRef Henein MY, O’Sullivan C, Sutton GC, et al. Stress-induced left ventricular outflow tract obstruction: a potential cause of dyspnea in the elderly. J Am Coll Cardiol 1997; 30: 1301–7PubMedCrossRef
16.
go back to reference Barletta G, Del Bene MR, Gallini C, et al. The clinical impact of dynamic intraventricular obstruction during dobutamine stress echocardiography. Int J Cardiol 1999; 70: 179–89PubMedCrossRef Barletta G, Del Bene MR, Gallini C, et al. The clinical impact of dynamic intraventricular obstruction during dobutamine stress echocardiography. Int J Cardiol 1999; 70: 179–89PubMedCrossRef
17.
go back to reference Rehman HU. Age and the cardiovascular system. Hosp Med 1999; 60: 645–50PubMed Rehman HU. Age and the cardiovascular system. Hosp Med 1999; 60: 645–50PubMed
18.
go back to reference Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988; 63: 552–64PubMedCrossRef Lie JT, Hammond PI. Pathology of the senescent heart: anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 1988; 63: 552–64PubMedCrossRef
19.
20.
go back to reference Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993; 73: 413–67PubMed Lakatta EG. Cardiovascular regulatory mechanisms in advanced age. Physiol Rev 1993; 73: 413–67PubMed
21.
go back to reference Roberts WC, Shirani J. Comparison of cardiac findings at necropsy in octogenarians, nonagenerains, and centenarians. Am J Cardiol 1998; 82: 627–31PubMedCrossRef Roberts WC, Shirani J. Comparison of cardiac findings at necropsy in octogenarians, nonagenerains, and centenarians. Am J Cardiol 1998; 82: 627–31PubMedCrossRef
22.
23.
24.
go back to reference Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000; 160: 1805–9CrossRef Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 2000; 160: 1805–9CrossRef
26.
go back to reference Rajkumar C, Kingwell BA, Cameron JD, et al. Hormonal therapy increases arterial compliance in postmenopausal women. Atherosclerosis 1997; 30: 350–6 Rajkumar C, Kingwell BA, Cameron JD, et al. Hormonal therapy increases arterial compliance in postmenopausal women. Atherosclerosis 1997; 30: 350–6
27.
go back to reference Van Bortel LM, Kool MJ, Spek JJ. Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension. Am J Cardiol 1995; 76(15): 46E–9EPubMedCrossRef Van Bortel LM, Kool MJ, Spek JJ. Disparate effects of antihypertensive drugs on large artery distensibility and compliance in hypertension. Am J Cardiol 1995; 76(15): 46E–9EPubMedCrossRef
28.
go back to reference Avolio AP, Clyde CM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986; 6: 166–9PubMedCrossRef Avolio AP, Clyde CM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis 1986; 6: 166–9PubMedCrossRef
29.
go back to reference Weinberg AD, Minaker KL. Dehydration: evaluation and management in older adults. Council on Scientific Affairs, American Medical Association. JAMA 1995; 274: 1552–6PubMedCrossRef Weinberg AD, Minaker KL. Dehydration: evaluation and management in older adults. Council on Scientific Affairs, American Medical Association. JAMA 1995; 274: 1552–6PubMedCrossRef
30.
31.
32.
go back to reference Matz RL, Schott C, Stoclet JC, et al. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res 2000; 49: 11–8PubMed Matz RL, Schott C, Stoclet JC, et al. Age-related endothelial dysfunction with respect to nitric oxide, endothelium-derived hyperpolarizing factor and cyclooxygenase products. Physiol Res 2000; 49: 11–8PubMed
33.
go back to reference Reaven PD, Napoli C, Merat S, et al. Lipoprotein modification and atherosclerosis in aging. Exp Gerontol 1999; 34: 4527–37CrossRef Reaven PD, Napoli C, Merat S, et al. Lipoprotein modification and atherosclerosis in aging. Exp Gerontol 1999; 34: 4527–37CrossRef
34.
go back to reference Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 2000; 293: 31–52PubMedCrossRef Van Lente F. Markers of inflammation as predictors in cardiovascular disease. Clin Chim Acta 2000; 293: 31–52PubMedCrossRef
35.
go back to reference Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628–37PubMedCrossRef Gottdiener JS, Arnold AM, Aurigemma GP, et al. Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2000; 35: 1628–37PubMedCrossRef
36.
go back to reference Kyne L, Hausdorff JM, Knight E, et al. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000; 139: 94–100PubMedCrossRef Kyne L, Hausdorff JM, Knight E, et al. Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J 2000; 139: 94–100PubMedCrossRef
37.
go back to reference Weisfeldt ML, Loeven WA, Shock NW. Resting and active mechanical properties of trabeculae carnae from aged male rats. Am J Physiol 1971; 220: 1921–7PubMed Weisfeldt ML, Loeven WA, Shock NW. Resting and active mechanical properties of trabeculae carnae from aged male rats. Am J Physiol 1971; 220: 1921–7PubMed
38.
go back to reference Lómpre A. The sarco(endo)plasmic reticululum Ca2+-ATPases in the cardiovascular system during growth and proliferation. Trends Cardiovasc Med 1998; 8: 75–82PubMedCrossRef Lómpre A. The sarco(endo)plasmic reticululum Ca2+-ATPases in the cardiovascular system during growth and proliferation. Trends Cardiovasc Med 1998; 8: 75–82PubMedCrossRef
39.
go back to reference Bak MI, Wei JY, Ingwall JS. Interaction of hypoxia and aging in the heart: analysis of high energy phosphate content. J Mol Cell Cardiol 1998; 30: 661–72PubMedCrossRef Bak MI, Wei JY, Ingwall JS. Interaction of hypoxia and aging in the heart: analysis of high energy phosphate content. J Mol Cell Cardiol 1998; 30: 661–72PubMedCrossRef
40.
41.
go back to reference Stratton JR, Cerqueira MD, Schwartz RS, et al. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation 1992; 86: 504–12PubMedCrossRef Stratton JR, Cerqueira MD, Schwartz RS, et al. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation 1992; 86: 504–12PubMedCrossRef
42.
go back to reference Turner MJ, Mier CM, Spina RJ, et al. Effects of age and gender on cardiovascular responses to isoproterenol. J Gerontol A Biol Sci Med Sci 1999; 54: B393–400PubMedCrossRef Turner MJ, Mier CM, Spina RJ, et al. Effects of age and gender on cardiovascular responses to isoproterenol. J Gerontol A Biol Sci Med Sci 1999; 54: B393–400PubMedCrossRef
43.
go back to reference Poller U, Nedelka G, Radke J, et al. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol 1997; 29: 187–93PubMedCrossRef Poller U, Nedelka G, Radke J, et al. Age-dependent changes in cardiac muscarinic receptor function in healthy volunteers. J Am Coll Cardiol 1997; 29: 187–93PubMedCrossRef
45.
go back to reference Matsubayashi K, Okumiya K, Wada T, et al. Postural dysregulation in systolic blood pressure in associated with worsened scoring on neurobehavioral function tests and leukoariosis in the older elderly living in a community. Stroke 1997; 28: 2169–73PubMedCrossRef Matsubayashi K, Okumiya K, Wada T, et al. Postural dysregulation in systolic blood pressure in associated with worsened scoring on neurobehavioral function tests and leukoariosis in the older elderly living in a community. Stroke 1997; 28: 2169–73PubMedCrossRef
46.
go back to reference Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995; 122: 286–95PubMed Jansen RW, Lipsitz LA. Postprandial hypotension: epidemiology, pathophysiology, and clinical management. Ann Intern Med 1995; 122: 286–95PubMed
47.
go back to reference Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998; 105(1A): 32S–9SPubMedCrossRef Quyyumi AA. Endothelial function in health and disease: new insights into the genesis of cardiovascular disease. Am J Med 1998; 105(1A): 32S–9SPubMedCrossRef
48.
go back to reference Andrawis N, Jones DS, Abernethy DR. Aging is associated with endothelial dysfunction in the human forearm vasculature. J Am Geriatr Soc 2000; 48: 193–8PubMed Andrawis N, Jones DS, Abernethy DR. Aging is associated with endothelial dysfunction in the human forearm vasculature. J Am Geriatr Soc 2000; 48: 193–8PubMed
49.
go back to reference Henderson A. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Int J Cardiol 1997; 62Suppl. 1: S43–8PubMedCrossRef Henderson A. Endothelial dysfunction: a reversible clinical measure of atherogenic susceptibility and cardiovascular inefficiency. Int J Cardiol 1997; 62Suppl. 1: S43–8PubMedCrossRef
50.
go back to reference Virdis A, Ghiadoni L, Taddei S, et al. Vitamin C improves agerelated endothehal dysfunction in humans [abstract]. Hypertension 1998: 32: 791 Virdis A, Ghiadoni L, Taddei S, et al. Vitamin C improves agerelated endothehal dysfunction in humans [abstract]. Hypertension 1998: 32: 791
51.
go back to reference Simons LA, von Konigsmark M, Simons J, et al. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. Atherosclerosis 1999; 143: 193–9PubMedCrossRef Simons LA, von Konigsmark M, Simons J, et al. Vitamin E ingestion does not improve arterial endothelial dysfunction in older adults. Atherosclerosis 1999; 143: 193–9PubMedCrossRef
52.
go back to reference Wick G, Perschinka H, Xu Q. Autoimmunity and atherosclerosis. Am Heart J 1999; 138 (5 Pt 2): S444–9PubMedCrossRef Wick G, Perschinka H, Xu Q. Autoimmunity and atherosclerosis. Am Heart J 1999; 138 (5 Pt 2): S444–9PubMedCrossRef
53.
go back to reference Muscari C, Giaccare A, Giordano E, et al. Role of reactive oxygen species in cardiovascular aging. Mol Cell Biochem 1996; 160/161: 159–66CrossRef Muscari C, Giaccare A, Giordano E, et al. Role of reactive oxygen species in cardiovascular aging. Mol Cell Biochem 1996; 160/161: 159–66CrossRef
54.
go back to reference Pryor W. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000; 28: 141–64PubMedCrossRef Pryor W. Vitamin E and heart disease: basic science to clinical intervention trials. Free Radic Biol Med 2000; 28: 141–64PubMedCrossRef
55.
go back to reference Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center: caloric intake and aging. N Engl J Med 1997; 337: 986–94PubMedCrossRef Weindruch R, Sohal RS. Seminars in medicine of the Beth Israel Deaconess Medical Center: caloric intake and aging. N Engl J Med 1997; 337: 986–94PubMedCrossRef
56.
go back to reference Odiet JA, Wei JY. Heart failure and the aging myocardium: possible role of cardiac mitochondria. Heart Failure Rev 1996; 2: 139–49CrossRef Odiet JA, Wei JY. Heart failure and the aging myocardium: possible role of cardiac mitochondria. Heart Failure Rev 1996; 2: 139–49CrossRef
57.
go back to reference Ferder L, Romano LA, Ercole LB, et al. Biomolecular changes in the aging myocardium: the effect of enalapril. Am J Hypertens 1998; 11: 1297–304PubMedCrossRef Ferder L, Romano LA, Ercole LB, et al. Biomolecular changes in the aging myocardium: the effect of enalapril. Am J Hypertens 1998; 11: 1297–304PubMedCrossRef
58.
go back to reference Bierhaus A, Hoffman MA, Zeigler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998; 37: 586–600PubMedCrossRef Bierhaus A, Hoffman MA, Zeigler R, et al. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998; 37: 586–600PubMedCrossRef
59.
go back to reference Corman B, Duriez M, Poitevin P, et al. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci U S A 1998; 95: 1301–6PubMedCrossRef Corman B, Duriez M, Poitevin P, et al. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy. Proc Natl Acad Sci U S A 1998; 95: 1301–6PubMedCrossRef
60.
go back to reference MacLellan WR, Schneider MD. Death by design: programmed cell death in cardiovascular biology and disease. Circ Res 1997; 81: 137–44PubMedCrossRef MacLellan WR, Schneider MD. Death by design: programmed cell death in cardiovascular biology and disease. Circ Res 1997; 81: 137–44PubMedCrossRef
62.
go back to reference Schmidt U, del Monte F, Miyamoto MI, et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca2+-ATPase. Circulation 2000; 101: 790–6PubMedCrossRef Schmidt U, del Monte F, Miyamoto MI, et al. Restoration of diastolic function in senescent rat hearts through adenoviral gene transfer of sarcoplasmic reticulum Ca2+-ATPase. Circulation 2000; 101: 790–6PubMedCrossRef
63.
go back to reference Maharam LG, Bauman PA, Kalman D, et al. Masters athletes: factors affecting performance. Sports Med 1999; 4: 273–85CrossRef Maharam LG, Bauman PA, Kalman D, et al. Masters athletes: factors affecting performance. Sports Med 1999; 4: 273–85CrossRef
64.
go back to reference Andersen R, Christmas C. Exercise and older patients: guidelines for the clinician. J Am Geriatr Soc 2000; 48: 318–24PubMed Andersen R, Christmas C. Exercise and older patients: guidelines for the clinician. J Am Geriatr Soc 2000; 48: 318–24PubMed
65.
go back to reference Schulman SP, Fleg JL, Goldberg AP, et al. Continium of cardiovascular performance across a broad range of fitness levels in healthy older men. Circulation 1996; 94: 359–67PubMedCrossRef Schulman SP, Fleg JL, Goldberg AP, et al. Continium of cardiovascular performance across a broad range of fitness levels in healthy older men. Circulation 1996; 94: 359–67PubMedCrossRef
66.
go back to reference Forman DE, Manning WJ, Hauser R, et al. Enhanced left ventricular diastolic filling associated with long-term endurance training. J Gerontol 1992; 47: M56–8PubMedCrossRef Forman DE, Manning WJ, Hauser R, et al. Enhanced left ventricular diastolic filling associated with long-term endurance training. J Gerontol 1992; 47: M56–8PubMedCrossRef
67.
go back to reference Wei JY, Li YX, Lincoln T, et al. Chronic exercise training protects aged cardiac muscle against hypoxia. J Clin Invest 1989; 83: 778–84PubMedCrossRef Wei JY, Li YX, Lincoln T, et al. Chronic exercise training protects aged cardiac muscle against hypoxia. J Clin Invest 1989; 83: 778–84PubMedCrossRef
68.
go back to reference Bulpitt CJ, Rajkumar C, Cameron JD. Vascular compliance as a measure of biological age. J Am Geriatr Soc 1999; 47: 657–63PubMed Bulpitt CJ, Rajkumar C, Cameron JD. Vascular compliance as a measure of biological age. J Am Geriatr Soc 1999; 47: 657–63PubMed
69.
go back to reference Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281: 634–49PubMedCrossRef Chae CU, Pfeffer MA, Glynn RJ, et al. Increased pulse pressure and risk of heart failure in the elderly. JAMA 1999; 281: 634–49PubMedCrossRef
70.
go back to reference Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993: 88: 1456–62PubMedCrossRef Vaitkevicius PV, Fleg JL, Engel JH, et al. Effects of age and aerobic capacity on arterial stiffness in healthy adults. Circulation 1993: 88: 1456–62PubMedCrossRef
71.
go back to reference Cameron JD, Dart AM. Exercise training increases total systemic arterial comphance in humans. Am J Physiol 1994; 266: H693–701PubMed Cameron JD, Dart AM. Exercise training increases total systemic arterial comphance in humans. Am J Physiol 1994; 266: H693–701PubMed
73.
go back to reference Willenheimer R. Left ventricular remodelling and dysfunction: can the process be prevented? Int J Cardiol 2000; 72: 143–50PubMedCrossRef Willenheimer R. Left ventricular remodelling and dysfunction: can the process be prevented? Int J Cardiol 2000; 72: 143–50PubMedCrossRef
74.
go back to reference Delcayre C, Silvestre JS. Aldosterone and the heart: towards a physiological function? Cardiovasc Res 1999; 43: 7–12PubMedCrossRef Delcayre C, Silvestre JS. Aldosterone and the heart: towards a physiological function? Cardiovasc Res 1999; 43: 7–12PubMedCrossRef
75.
go back to reference Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study investigators. N Engl J Med 1999; 341: 709–17PubMedCrossRef Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study investigators. N Engl J Med 1999; 341: 709–17PubMedCrossRef
76.
go back to reference Paulus WJ, Shah AM. NO and cardiac diastolic function. Cardiovasc Research 1999; 43: 595–606CrossRef Paulus WJ, Shah AM. NO and cardiac diastolic function. Cardiovasc Research 1999; 43: 595–606CrossRef
Metadata
Title
Clinical Implications of Physiological Changes in the Aging Heart
Authors
K. Gregory Pugh
Dr Jeanne Y. Wei
Publication date
01-04-2001
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 4/2001
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200118040-00004

Other articles of this Issue 4/2001

Drugs & Aging 4/2001 Go to the issue

Adis Drug Evaluation

Tolterodine

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.